APA (7th ed.) Citation

A, Y., C, N., A, R., F, L., NS, D., CL, H., . . . AR, S. (2024). A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI). Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 23(5), 984. https://doi.org/10.1016/j.jcf.2024.08.001

Chicago Style (17th ed.) Citation

A, Yule, et al. "A Longitudinal Study Assessing the Impact of Elexacaftor/tezacaftor/ivacaftor on Gut Transit and Function in People with Cystic Fibrosis Using Magnetic Resonance Imaging (MRI)." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society 23, no. 5 (2024): 984. https://doi.org/10.1016/j.jcf.2024.08.001.

MLA (9th ed.) Citation

A, Yule, et al. "A Longitudinal Study Assessing the Impact of Elexacaftor/tezacaftor/ivacaftor on Gut Transit and Function in People with Cystic Fibrosis Using Magnetic Resonance Imaging (MRI)." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, vol. 23, no. 5, 2024, p. 984, https://doi.org/10.1016/j.jcf.2024.08.001.